CT Financial Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

CT Financial Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$470	Hold	2,000	–	–	﹤0.01%	611
2016 Q4	$730	Hold	2,000	–	–	﹤0.01%	599
2016 Q3	$748	Hold	2,000	–	–	﹤0.01%	598
2016 Q2	$810	Hold	2,000	–	–	﹤0.01%	590
2016 Q1	$940	Hold	2,000	–	–	﹤0.01%	580
2015 Q4	$1.36K	Hold	2,000	–	–	﹤0.01%	575
2015 Q3	$1.94K	Hold	2,000	–	–	﹤0.01%	580
2015 Q2	$2.4K	Hold	2,000	–	–	﹤0.01%	565
2015 Q1	$2.12K	Sell	2,000 -990	-33%	-$1.02K	﹤0.01%	563
2014 Q4	$3.26K	Buy	+2,990	New	+$3.14K	﹤0.01%	456
2014 Q1	$2.12K	Buy	+2,000	New	+$2.06K	﹤0.01%	563

Other funds holding ENZN

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CT Financial Advisors's ENZN Position: Q1 2017 in Review

CT Financial Advisors held its ENZON PHARMACEUTICALS INC (ENZN) position steady in Q1 2017 at 2,000 shares worth $470. The position accounts for ﹤0.01% of the portfolio, ranked #611.

CT Financial Advisors first reported a position in ENZN in Q1 2014 and has held it in 11 quarters since. The position peaked at $3.26K in Q4 2014. 2 funds tracked by Wall St. Rank hold ENZN as of Q1 2017.

CT Financial Advisors held 2,000 shares of ENZON PHARMACEUTICALS INC worth $470 as of Q1 2017.
CT Financial Advisors left its ENZON PHARMACEUTICALS INC share count unchanged in Q1 2017.
ENZON PHARMACEUTICALS INC made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #611 holding.
CT Financial Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's ENZON PHARMACEUTICALS INC position peaked at $3.26K in Q4 2014.
2 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.